PubMed Health⌕ Search

Biomedical subjects

B Berris

Publications and source records attributed to B Berris.

At least 37 records · Page 2Linked to original sources
PubMed1979

Failure to detect hepatitis B surface antigen (HBsAg) in feces of HBsAg-positive persons.

Since previous studies did not provide conclusive data regarding the presence of hepatitis B surface antigen (HBsAg) in the feces of HBsAg carriers, the feces of 20 HBsAg carriers and six patients with HBsAg-positive active liver disease were examined with use of a reproducible method for concentrating and detecting HBsAg in feces in which bovine serum, which has been shown to protect HBsAg destruction by fecal components, was added to the fecal specimens. HBsAg was not detected in 66 fecal specimens from the 26 HBs-Ag-positive persons. Furthermore, HBsAg could not be detected in the feces of a carrier who had ingested 4 ml of his own serum. This finding suggests that there are factors in the gastrointestinal tract that interfere with the immunoreactivity of the HBsAg and possibly destroy the hepatitis B virus. These findings explain why oral/fecal spread does not play a major role in the transmission of hepatitis B virus.

Carrier State↗
PubMed1978

Hepatitis and hepatitis B surface antigen and antibody in dentists.

Dentists were surveyed regarding a history of hepatitis and the presence in the blood of hepatitis B surface antigen (HBsAg) and antibody (anti-HBs) to determine whether they were at high risk of exposure to hepatitis B virus. Of 288 Canadian dentists 5.2% gave a history of hepatitis after graduation. This proportion is similar to that for 1462 Ontario dentists (6.3%) and that for 3162 accountants (5.1%) who had previously completed a mailed questionnaire. One dentist (0.3%) was HBsAg-positive and 42 (14.6%) were anti-HBs-positive. Of 210 healthy volunteer blood donors matched for age, sex and ethnic origin with the group of dentists none was HBsAg-positive and 2.9% significantly fewer (P less than 0.005), were anti-HBs-positive. Among Ontario blood donors 0.3% were HBsAg-positive and 3% were anti-HBs-positive. Thus, in Canada, dentists are not at increased risk of acquiring clinical hepatitis or becoming carriers, but they are more likely than other groups to have anti-HBs in the blood. Among dentists from outside Canada a higher proportion had a history of hepatitis (10.3%) and were HBsAg-positive (1.6%), but approximately the same proportion were anti-HBs-positive (15.9%).

Antibodies, Viral↗
PubMed1978

Hepatitis in undertakers.

Six of 106 undertakers (5.6%) gave a past history of hepatitis during their professional careers; this was no different from the frequency in a control group of 3,162 accountants (5.1%) who had no direct contact with blood. None of the undertakers or 210 blood donors matched for age, sex, and ethnic background had serum positive for hepatitis B surface antigen. Five undertakers (4.7%) had blood that was positive for antibody to hepatitis B surface antigen, compared with six of 210 (2.9%) in the control group; this difference was not statistically significant (P greater than .25). Thus, undertakers appear to be in a low-risk occupation with reference to acquisition of hepatitis B. Although the numbers are too small for statistical analysis, there appeared to be an increased exposure to hepatitis B in undertakers who take no preventive precautions. We recommend that the minimal precautions for undertakers be the wearing of gloves.

Adult↗
PubMed1976

Practical guidelines for assessing patients positive for hepatitis B surface antigen.

In assessing the patient the hepatitis B surface antigen (HBsAg) the physician must decide on the basis of physical findings, results of laboratory tests and biopsy, when indicated, whether the patient is an asymptomatic carrier or has acute or chronic hepatitis. Asymptomatic carriers of HBsAg must be educated in personal hygiene and the possibility of transmission, should not be allowed to donate blood or breast-feed and should not work with blood products for human use or pharmaceutical products designated for intravenous use. However, it is otherwise not necessary to advise these individuals to change their profession.

Carrier State↗
PubMed1976

Hepatitis B surface antigen and antibody in asymptomatic blood donors.

Seventy-two volunteer blood donors who had hepatitis B surface antibody (anti-HBS) were studied and compared with 115 carriers of hepatitis B surface antigen (HBSAg). Anti-BHS-positive donors gave a history of greater possible exposure to hepatitis B virus, there was a lower male-female ratio, and they had a much lower frequency of abnormal hepatic function test results. Those who were positive by counterimmunoelectrophoresis (CIEP), which indicated a high titer of antibody (greater than 1:2,000 as measured by passive hemagglutination assay [PHA], also had an ethnic origin similar to that of the donor panel, ie, predominantly Canadian and northern European. The HBSAg carriers, on the other hand, had a high frequency of origin from Mediterranean and Far Eastern countries. Low-antibody-titer (positive PHA but negative CIEP) donors had ethnic origins that more closely approximated those of HBSAg carriers.

Antibodies↗
PubMed1975

e antigen and anti-e in HBsAg carriers.

A new antigen/antibody system, "e" and anti-e, was described in 1972. In order to assess the clinical significance of e antigen and anti-e, their presence was correlated with the clinical status, S.G.P.T. levels and liver biopsies of HBsAg carriers. 31 of the carriers had liver biopsies, 32 of 70 carriers had anti-e and 2 had e antigen. 28 of 55 carriers with normal S.G.P.T. and 4 of 15 patients with raised S.G.P.T. had anti-e. This difference is not statistically significant. 2 patients with e had raised S.G.P.T. All patients with normal histology, 45% of patients with mild, and 23% of patients with striking histological changes in the liver had anti-e. This association of anti-e with a normal or mildly abnormal liver was statistically significant. The 2 patients with e antigen had the most severe abnormalities in liver function and liver histology.

Alanine Transaminase↗
PubMed1975

Atheromatous embolic disease.

In five patients with atheromatous embolic disease, the diagnosis was made before death in four -- on the basis of cholesterol emboli in the retina in three and from renal pathologic features in 1. Muscle biopsy demonstrated emboli in one patient, and emboli were seen in the vessels of amputated toes in two. All patients died of renal failure, but there was evidence of multisystem involvement in addition. Autopsy in four cases showed characteristic cholesterol emboli in many organs.

Aged↗
PubMed1975

Prevalence and significance of hepatitis B surface antigen in a general hospital.

Over a 6-month period 2025 patients admitted to New Mount Sinai Hospital, Toronto were screened for hepatitis B surface antigen (HBsAg) by counter-immunoelectrophoresis (CIEP) and radioimmunoassay (RIA). CIEP detected 12 HBsAg-positive patients and RIA 16. RIA is therefore the more sensitive test for HBsAg. Of the 16 patients 2 had liver disease previously diagnosed, 3 had malignant disease and 11 were asymptomatic carriers. Of the 11 carriers all were born in countries where the carrier rate is known to be high. Routine screening of hospital patients on admission is of no value in detecting unsuspected liver disease but is of value in detecting asymptomatic carriers, which is of importance for the patient and his family. Routine screening tests for HBsAg in Canadian hospitals that treat many patients born in countries with a known high HBsAg prevalence is recommended. Routine screening is also recommended in all hospitals in Mediterranean and Asian countries.

Carrier State↗
PubMed1975

Clinical and epidemiological significance of the HBSAg (Australia antigen): carrier state.

One hundred fifteen asymptomatic Australia antigen (HBSAg) carriers, discovered by routine testing of volunteer blood donors in Toronto, were investigated and followed for up to 30 months. The carrier state seems to be largely host-dependent, and its prevalence is modified by ethnic origin, sex, and age. A high prevalence of carriers was found in persons coming from Mediterranean countries and the Orient. The carrier state was 3 times more common in males than in females, and the majority of the carriers were under 30 years of age. Family clustering of HBSAg-positive individuals was observed. All carriers were asymptomatic and only one gave a history of jaundice in the past. Seven gave a history of intravenous drug use. Four had moderate hepatomegaly. Fifty-four had some abnormality in their liver function tests. The SGPT was the most frequently abnormal test and correlated best with the histological findings. Twenty of 29 liver biopsies showed features of chronic benign persisting hepatitis. All patients remained well during the follow-up period. In no patient was there evidence of deterioration or progression in either their clinical state, liver function, or pathological findings. Only 1 of the 115 carriers became HBSAg-negative over the period of observation.

Adult↗
PubMed1975

Hepatitis B surface antigen in saliva of HB-SAg carriers.

Two hundred and twelve saliva specimens of HB-SAg carriers were tested for HB-SAg by crossover immunoelectrophoresis (CIEP) and radioimmunoassay (RIA) after concentration, between April 1971 and September 1973. They were divided into 3 groups (A, B, and C). CIEP detected HG-SAg in 6 per cent in Group A (66 specimens) and in 12 percent in Group B (87 specimens), and in 78 per cent in Group C. Different methods of preparation and concentration of saliva specimens were discussed. The positive results by RIA were confirmed by a blocking test with rabbit HB-SAg antiserum. Intermittent presence of HB-SAg in repeated saliva specimens from individual carriers was found. Infected saliva of HB-SAg carriers may be of importance in transmission of hepatitis B infection.

Animals↗
PubMed1973

Reporting of post-transfusion jaundice.

Reports of post-transfusion jaundice were analysed in four successive years from April 1, 1969 to April 1, 1973. Analysis showed a marked reduction in the number of cases reported during the two years of routine HBAg-testing of all blood donations as compared with the two years before this testing was instituted. The value of retrospective studies under present conditions of reporting is discussed.

Blood Banks↗
PubMed1973

Frequency of hepatitis B antigen in blood donors.

Routine testing of all blood donations for hepatitis B antigen by counter-immunoelectrophoresis was started in April 1971. The frequency of HBAg carriers among apparently healthy volunteer blood donors in the Toronto Centre of the Canadian Red Cross Blood Transfusion Service was 15 in 10,000 with a male:female ratio of 6:1. Excluding penitentiary inmates, the highest incidence was among young, male, non-Anglo-Saxon city dwellers.A system of notification of HBAg-positive donors was developed, through which a carrier is referred to a special clinic for clinical and pathological evaluation.A survey of hospital patients indicated an incidence of HB antigen 3.5 times that of our healthy donor population. A comparison of the number of post-transfusion hepatitis cases occurring before and after the commencement of routine testing for HBAg showed a marked reduction in reported cases in 1971.

Adolescent↗